DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Bonaca MP, Nault P, Giugliano RP. et al.
Low density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER Trial (further cardiovascular outcomes research with PCSK9 inhibition in subjects with elevated risk).
Circulation 2018;
137: 338-350
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.